ONCAlert | Upfront Therapy for mRCC
Lymphomas: Articles
A Look Back at FDA News from November 2019
3:49 PM, Mon December 2, 2019
Contemporary Therapy for Advanced-Stage Hodgkin Lymphoma
9:00 PM, Tue November 26, 2019
Tafasitamab/Chemotherapy DLBCL Study Passes Event-Driven Interim Analysis for Futility
10:40 PM, Tue November 19, 2019
A Look Back at FDA News from October 2019
1:36 PM, Fri November 1, 2019
Real-World Data Confirm Superiority of Tafasitamab/Lenalidomide Regimen in R/R DLBCL
8:29 PM, Wed October 30, 2019
Advances From the World Conference on Lung Cancer and New Developments in Relapsed Lymphoma and Immunotherapy
6:00 PM, Wed October 16, 2019
Pro Discusses Options for Patients With Advanced-Stage Hodgkin Lymphoma
6:00 PM, Thu October 10, 2019
Duvelisib Gains FDA Orphan Drug Designation for T-Cell Lymphomas
4:00 PM, Fri October 4, 2019
